MedPath

Evaluation of CD271 expression as a prognostic factor in non-small cell lung cancer patients

Not Applicable
Recruiting
Conditions
on-small cell lung cancer
Registration Number
JPRN-UMIN000046024
Lead Sponsor
Shiga University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have refused to allow their samples and information to be used in this research

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence-free survival (RFS)
Secondary Outcome Measures
NameTimeMethod
Overall survival (OS) Association between CD271 staining intensity and clinicopathological findings in non-small cell lung cancer Relationship between the staining intensity of CD271 and the staining intensity of nerve growth factor receptor (NGF, BDGF, Neutrophin) and cancer stromal fibroblast marker molecules (alfa smooth muscle Actin, podoplanin)
© Copyright 2025. All Rights Reserved by MedPath